BIOMAT Database Logo BIOMAT Database Logo

Synthesis and antileukemic activity of novel 2-(4-(2,4-dimethoxybenzoyl)phenoxy)-1-(4-(3-(piperidin-4-yl)propyl)piperidin-1-yl)ethanone derivatives. 2012

Kambappa Vinaya, and Chandagirikoppal V Kavitha, and Doddakunche S Prasanna, and Siddappa Chandrappa, and Somasagara R Ranganatha, and Sathees C Raghavan, and Kanchugarakoppal S Rangappa

A series of novel 2-(4-(2,4-dimethoxybenzoyl)phenoxy)-1-(4-(3-(piperidin-4-yl)propyl) piperidin-1-yl)ethanone derivatives 9(a-e) and 10(a-g) were synthesized and characterized by (1) H NMR, IR, mass spectral, and elemental analysis. These novel compounds were evaluated for their antileukemic activity against two human leukemic cell lines (K562 and CEM) by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide assay. Some of the tested compounds showed good antiproliferative activity with IC(50) values ranging from 1.6 to 8.0 μm. Compound 9c, 9e, and 10f with an electron-withdrawing halogen substituent at the para position on the phenyl ring showed excellent in vitro potency against tested human leukemia cells (K562 and CEM).

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D010880 Piperidines A family of hexahydropyridines.
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001577 Benzophenones Derivatives of benzophenone (with the structural formula phenyl-(C
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Kambappa Vinaya, and Chandagirikoppal V Kavitha, and Doddakunche S Prasanna, and Siddappa Chandrappa, and Somasagara R Ranganatha, and Sathees C Raghavan, and Kanchugarakoppal S Rangappa
Evaluation of in vivo wound-healing potential of 2-[4-(2,4-dimethoxy-benzoyl)-phenoxy]-1-[4-(3-piperidin-4-yl-propyl)-piperidin-1-yl]-ethanone derivatives.
August 2009, European journal of medicinal chemistry,
Kambappa Vinaya, and Chandagirikoppal V Kavitha, and Doddakunche S Prasanna, and Siddappa Chandrappa, and Somasagara R Ranganatha, and Sathees C Raghavan, and Kanchugarakoppal S Rangappa
2-Chloro-1-[4-(2,4-difluoro-benz-yl)piperazin-1-yl]ethanone.
January 2012, Acta crystallographica. Section E, Structure reports online,
Kambappa Vinaya, and Chandagirikoppal V Kavitha, and Doddakunche S Prasanna, and Siddappa Chandrappa, and Somasagara R Ranganatha, and Sathees C Raghavan, and Kanchugarakoppal S Rangappa
Synthesis and hypolipidemic activity of novel 2-(4-(2-substituted aminothiazole-4-yl) phenoxy) acetic acid derivatives.
July 2010, European journal of medicinal chemistry,
Kambappa Vinaya, and Chandagirikoppal V Kavitha, and Doddakunche S Prasanna, and Siddappa Chandrappa, and Somasagara R Ranganatha, and Sathees C Raghavan, and Kanchugarakoppal S Rangappa
Synthesis and antifungal activity of (+/-)-1-(5-aryl-3-pyridin-2-yl-4,5-dihydro-pyrazol-1-yl)-2-imidazol-1-yl-ethanone derivatives.
April 2003, Farmaco (Societa chimica italiana : 1989),
Kambappa Vinaya, and Chandagirikoppal V Kavitha, and Doddakunche S Prasanna, and Siddappa Chandrappa, and Somasagara R Ranganatha, and Sathees C Raghavan, and Kanchugarakoppal S Rangappa
Synthesis and dopaminergic activity of some E-3-(piperidin-1-yl)-1-(4-substituted phenyl)prop-2-en-1-one derivatives.
October 2009, Bioorganic & medicinal chemistry,
Kambappa Vinaya, and Chandagirikoppal V Kavitha, and Doddakunche S Prasanna, and Siddappa Chandrappa, and Somasagara R Ranganatha, and Sathees C Raghavan, and Kanchugarakoppal S Rangappa
1-{5-[(E)-(4-Propyl-phen-yl)diazen-yl]-2-hy-droxy-phen-yl}ethanone.
February 2011, Acta crystallographica. Section E, Structure reports online,
Kambappa Vinaya, and Chandagirikoppal V Kavitha, and Doddakunche S Prasanna, and Siddappa Chandrappa, and Somasagara R Ranganatha, and Sathees C Raghavan, and Kanchugarakoppal S Rangappa
Discovery of clinical candidate 1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (AMG 579), a potent, selective, and efficacious inhibitor of phosphodiesterase 10A (PDE10A).
August 2014, Journal of medicinal chemistry,
Kambappa Vinaya, and Chandagirikoppal V Kavitha, and Doddakunche S Prasanna, and Siddappa Chandrappa, and Somasagara R Ranganatha, and Sathees C Raghavan, and Kanchugarakoppal S Rangappa
1-(5-Chloro-2,4-dihydroxy-phen-yl)-2-(4-ethoxy-phen-yl)ethanone.
September 2008, Acta crystallographica. Section E, Structure reports online,
Kambappa Vinaya, and Chandagirikoppal V Kavitha, and Doddakunche S Prasanna, and Siddappa Chandrappa, and Somasagara R Ranganatha, and Sathees C Raghavan, and Kanchugarakoppal S Rangappa
Synthesis and pharmacological evaluation of new 1-[3-(4-phenylpiperazin-1-yl)-propyl]- and 1-[3-(4-phenylpiperidine)-propyl]- 3-aryl-3-alkyl-pyrrolidin-2-one derivatives with antiarrhythmic and antihypertensive activity.
January 2009, Acta poloniae pharmaceutica,
Kambappa Vinaya, and Chandagirikoppal V Kavitha, and Doddakunche S Prasanna, and Siddappa Chandrappa, and Somasagara R Ranganatha, and Sathees C Raghavan, and Kanchugarakoppal S Rangappa
Synthesis, Spectral Analysis, In Vitro Microbiological Evaluation, and Molecular Docking Studies of Some Novel 1-(1-Aryl-1H-tetrazol-5-yl)-2-(piperidin-1-yl)ethanone Derivatives.
January 2014, ISRN organic chemistry,
Copied contents to your clipboard!